At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Phototherapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Trial of Phototherapy for Acute Depression in Hospitalized CF Patients
In Brief
A clinical study evaluating Phototherapy for Depression and Cystic Fibrosis. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether bright light phototherapy can improve depressive symptoms in hospitalized patients with cystic fibrosis (CF) with subsequent effects on quality of life and illness recovery. It is hypothesized that phototherapy will improve depressive symptoms and decrease length of stay in depressed patients with CF who are hospitalized.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Cystic Fibrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedApr 2013
Primary CompletionMay 2015
Study CompletionJun 2015
TodayJul 2026
First PostedApr 2, 2013
Enrollment StartMar 1, 2013
Primary CompletionMay 1, 2015
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.3 years ago
Interventions
Phototherapydevice
light will be administered at a minimum distance of 12 inches away to provide 10,000 lux